Thomas P. Brady

1.2k total citations
19 papers, 958 citations indexed

About

Thomas P. Brady is a scholar working on Organic Chemistry, Molecular Biology and Cell Biology. According to data from OpenAlex, Thomas P. Brady has authored 19 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in Thomas P. Brady's work include Synthetic Organic Chemistry Methods (4 papers), Marine Sponges and Natural Products (4 papers) and Cellular transport and secretion (3 papers). Thomas P. Brady is often cited by papers focused on Synthetic Organic Chemistry Methods (4 papers), Marine Sponges and Natural Products (4 papers) and Cellular transport and secretion (3 papers). Thomas P. Brady collaborates with scholars based in United States. Thomas P. Brady's co-authors include Emmanuel A. Theodorakis, Darcy Lichlyter, Mark A. Haidekker, Ke Wen, Sun Hee Kim, Vivek Malhotra, Gianni Guizzunti, Sun Hee Kim, Peter Briggs and Walter J. Akers and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas P. Brady

19 papers receiving 940 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas P. Brady United States 13 429 349 285 234 135 19 958
Enrico Faggi Italy 19 312 0.7× 417 1.2× 573 2.0× 397 1.7× 49 0.4× 33 1.1k
Basab Roy United States 15 558 1.3× 664 1.9× 186 0.7× 554 2.4× 74 0.5× 25 1.3k
Velayutham Ravikumar Switzerland 12 267 0.6× 251 0.7× 463 1.6× 174 0.7× 167 1.2× 18 854
Gertz I. Likhtenshtein Israel 18 439 1.0× 141 0.4× 299 1.0× 216 0.9× 252 1.9× 61 1.0k
Isabelle L. Kirby United Kingdom 16 461 1.1× 944 2.7× 474 1.7× 387 1.7× 170 1.3× 17 1.3k
Eva M. Talavera Spain 20 585 1.4× 335 1.0× 156 0.5× 460 2.0× 258 1.9× 50 1.3k
Lucas McDonald United States 15 448 1.0× 377 1.1× 266 0.9× 254 1.1× 220 1.6× 18 892
Pablo Wessig Germany 23 462 1.1× 188 0.5× 1.5k 5.3× 416 1.8× 145 1.1× 119 2.1k
Matinder Kaur South Korea 13 438 1.0× 309 0.9× 392 1.4× 193 0.8× 48 0.4× 18 1.0k
Jana Donovalová Slovakia 14 333 0.8× 228 0.7× 263 0.9× 89 0.4× 148 1.1× 42 685

Countries citing papers authored by Thomas P. Brady

Since Specialization
Citations

This map shows the geographic impact of Thomas P. Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Brady more than expected).

Fields of papers citing papers by Thomas P. Brady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Brady. The network helps show where Thomas P. Brady may publish in the future.

Co-authorship network of co-authors of Thomas P. Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Brady. A scholar is included among the top collaborators of Thomas P. Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Brady. Thomas P. Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Döhrmann, Simon, Jason N. Cole, Karin Amundson, et al.. (2023). 2062. In Vivo Efficacy of CD388, a Novel Drug Fc-Conjugate (DFC), Against Seasonal Subtypes of Influenza in Prophylaxis in Immune Competent Mice, and in a Severe Immunodeficient (SCID) Mouse Model. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
2.
Döhrmann, Simon, Qiping Zhao, María Hernández, et al.. (2023). 1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer. SHILAP Revista de lepidopterología. A1318–A1318. 1 indexed citations
3.
Döhrmann, Simon, Karin Amundson, Thomas P. Brady, et al.. (2020). 162. CD377, a Novel Antiviral Fc-conjugate, Demonstrates Potent Viral Burden Reduction Against Influenza a (H1N1) in Mouse and Ferret Models. Open Forum Infectious Diseases. 7(Supplement_1). S210–S211. 1 indexed citations
4.
Guizzunti, Gianni, et al.. (2010). Chemical biology studies on norrisolide. Bioorganic & Medicinal Chemistry. 18(6). 2115–2122. 14 indexed citations
5.
Zhou, Yuefen, Linyi Wei, Thomas P. Brady, et al.. (2009). Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives as novel small molecule chaperone amplifiers. Bioorganic & Medicinal Chemistry Letters. 19(15). 4303–4307. 12 indexed citations
6.
Guizzunti, Gianni, Thomas P. Brady, Vivek Malhotra, & Emmanuel A. Theodorakis. (2006). Trifunctional norrisolide probes for the study of Golgi vesiculation. Bioorganic & Medicinal Chemistry Letters. 17(2). 320–325. 11 indexed citations
7.
Guizzunti, Gianni, Thomas P. Brady, Vivek Malhotra, & Emmanuel A. Theodorakis. (2006). Chemical Analysis of Norrisolide-Induced Golgi Vesiculation. Journal of the American Chemical Society. 128(13). 4190–4191. 29 indexed citations
8.
Brady, Thomas P., Sun Hee Kim, Ke Wen, Charles C. Kim, & Emmanuel A. Theodorakis. (2005). Norrisolide: Total Synthesis and Related Studies. Chemistry - A European Journal. 11(24). 7175–7190. 48 indexed citations
9.
Haidekker, Mark A., Thomas P. Brady, Darcy Lichlyter, & Emmanuel A. Theodorakis. (2005). A Ratiometric Fluorescent Viscosity Sensor. Journal of the American Chemical Society. 128(2). 398–399. 260 indexed citations
10.
Haidekker, Mark A., Thomas P. Brady, Darcy Lichlyter, & Emmanuel A. Theodorakis. (2005). Effects of solvent polarity and solvent viscosity on the fluorescent properties of molecular rotors and related probes. Bioorganic Chemistry. 33(6). 415–425. 365 indexed citations
11.
Haidekker, Mark A., Walter J. Akers, Darcy Lichlyter, Thomas P. Brady, & Emmanuel A. Theodorakis. (2005). Sensing of Flow and Shear Stress Using Fluorescent Molecular Rotors. Sensor Letters. 3(1). 42–48. 19 indexed citations
12.
Brady, Thomas P., et al.. (2004). Fragmentation of Golgi membranes by norrisolide and designed analogues. Bioorganic & Medicinal Chemistry Letters. 14(20). 5035–5039. 23 indexed citations
13.
Brady, Thomas P., Sun Hee Kim, Ke Wen, & Emmanuel A. Theodorakis. (2004). Stereoselective Total Synthesis of (+)‐Norrisolide. Angewandte Chemie International Edition. 43(6). 739–742. 57 indexed citations
14.
Haidekker, Mark A., et al.. (2004). Hydrophilic molecular rotor derivatives—synthesis and characterization. Bioorganic Chemistry. 32(4). 274–289. 46 indexed citations
15.
Brady, Thomas P., Sun Hee Kim, Ke Wen, & Emmanuel A. Theodorakis. (2004). Stereoselective Total Synthesis of (+)‐Norrisolide. Angewandte Chemie. 116(6). 757–760. 18 indexed citations
16.
Brady, Thomas P., et al.. (1973). Formation of dibenzodioxins and other condensation products from chlorinated phenols and derivatives.. Environmental Health Perspectives. 5. 3–7. 32 indexed citations
17.
Brady, Thomas P., et al.. (1973). Thermal reactions by automated mass spectrometric thermal analysis. Thermochimica Acta. 5(4). 391–402. 16 indexed citations
18.
Brady, Thomas P.. (1957). Segregation and the South. 3 indexed citations
19.
Brady, Thomas P.. (1954). A Review of Black Monday. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026